DSM reports results first nine months 2020
DSM reports a solid first nine months in a challenging COVID-19 environment, with a continuing robust performance in Q3.
03 Nov 2020
Royal DSM is a global purpose-led, science-based company in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. With its products and solutions DSM addresses some of the world’s biggest challenges whilst creating simultaneously economic, environmental and societal value for all its stakeholders; customers, employees, shareholders, and society-at-large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.
2019
Sales: ↑€2,892 (2018: €2,749)
Organic Growth: ↑4%
Volume Growth: ↑2%
Price Growth: ↑2%
2019
Sales: ↑€2,046 (2018: €1,989)
Organic Growth: ↓1%
Volume Growth: ↑2%
Price Growth: ↓3%
2019
Sales: ↑€572 (2018: €490)
Sales: ↑17%
Organic Growth: ↑4
2019
Sales: ↑€425 (2018: €382)
Sales: ↑11%
Organic Growth: ↑9%
1) Underlying business, net of temporary vitamin effect
Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.
2019
Sales: ↓€1,406 (2018: €1,516)
Organic Growth: ↓10%
2019
Sales: ↓€338 (2018: €344)
Organic Growth: ↓4%
2019
Sales: ↓€1,002 (2018: €1,053)
Organic Growth: ↓6%
DSM reports a solid first nine months in a challenging COVID-19 environment, with a continuing robust performance in Q3.
03 Nov 2020
DSM’s Resins & Functional Materials businesses moved to discontinued operations with their agreed sale to Covestro AG.
08 Oct 2020
DSM acquires Erber's Biomin specialty animal nutrition and health & Romer Labs food/feed safety diagnostics businesses.
02 Oct 2020
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014. Her current term will end in 2022.
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013. His current term will end in 2021.
Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.
An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.
DSM's share performance in real time and historically.